top of page

Visura Proud Supporter of Mayo Clinic Echocardiography Conferences

TEECAD Innovation to be Showcased at Upcoming Mayo Clinic Continuing Education and American Society of Echocardiography (ASE) Meetings


MINNEAPOLIS, MN (December 5, 2022) —Visura Technologies, Inc., a privately-held medical device company dedicated to delivering state-of-the-art visualization solutions to improve the safety and success of transesophageal echocardiogram (TEE) probe intubations, shared today they will be attending the Mayo continuing medical education conference, Echo: Case-based Approach on Marco Island December 11-15 in Florida. This conference of the world’s top echocardiography physicians presents a unique opportunity for Visura to showcase the TEECAD System - the world’s first, FDA-cleared disposable camera that seamlessly connects to TEE probes to support first pass intubation success and reduce TEE procedural complications.


“Visura is honored to sponsor this event and offer attendees the chance to have a first-hand TEECAD experience, view footage from procedures, and learn how they can bring the TEECAD solution to their patients. Similar to the Mayo meeting, Cases in Echocardiography, Cardiac CT, and MRI that Visura supported in October, we feel the small meetings are the perfect atmosphere to share this game-changing solution with physicians,” shared Christine Horton, Chief Executive Officer of Visura. “We invite attendees to stop by our table and pick up a white paper by Dr. Sunil Mankad, Professor of Medicine, Director of Transesophageal Echocardiography and Co-Chair of Education, Division of Cardiovascular Ultrasound at Mayo Clinic in Rochester, MN to learn more about his first-hand experience with TEECAD.

In addition to the Mayo educational meetings, Visura will also attend the ASE State-of-the-Art Echocardiography meeting, February 18-20, in Scottsdale, Arizona. New data about the efficiency and effectiveness of the TEECAD System will be shared at this meeting.


In recent months, the base of TEECAD users across the United States has grown to include many of the premier hospitals and key opinion leaders in echocardiography. To learn more about bringing TEECAD to your institution, visit us at an upcoming conference or online at www.visuratechnologies.com.


About Visura

Founded in 2015, Visura is a medical device company dedicated to delivering state-of-art visualization solutions to improve the safety and success of TEE probe intubation. They have developed the TEECAD System, the world's first, FDA-cleared, disposable camera that seamlessly connects to a TEE probe, providing physicians real-time visualization for more efficient and effective probe placement to support first pass intubation success.

Comments


VIS_CoreVisualDeviceRender cropped 150dpi.png

The following U.S. and international patents apply to Visura Technologies products listed below, or use thereof.

This page is intended to serve as notice under 35 U.S.C. § 287(a).

US 10,265,046​​

US 10,045,758

​​

US 10,376,237

​​​

​Other Patents Pending. Updated 7/8/24.

US 10,925,576

JP 6668348

EU 3223713 B1

©2025 | Visura Technologies Inc. | All Rights Reserved | AP-GEN2-004 Rev C

TEECAD is a trademark of Visura Technolgies, Inc., registered in the U. S. and other countries.

2. Ozturk et al Use of McGrath MAC Video laryngoscope to AssistTransesophageal Echocardiography Probe Insertion in Intubated Patients. Journal of Cardiothoracic Anesthesia 2017 Feb

1. Mankad, S. Early results of the TEECAD System in 15 TEE paients at the Mayo Clinic Rochester.

  • Twitter
  • LinkedIn

Visura Technologies, Inc.

8400 Normandale Lake Blvd

Suite 920
Bloomington, MN  55437

info@visuratechnologies.com

 

bottom of page